InvestSMART

Proteomics International Laboratories Ltd (ASX:PIQ)

ALERT: Price-sensitive ASX Announcement for PIQ
Current share price for PIQ : $0.165 -0.085 (-34%)+
Release
17 Apr 2026 9:21AM
Price at Release
$0.250
Full Release
download
Summary
Proteomics International Laboratories Ltd announced a series of organisational and leadership changes as part of a strategic review aimed at transitioning the company from a research-driven organisation to a commercially-focused diagnostics company. The restructure includes a reduction of 25% of its workforce, resulting in annual cost savings of over $1 million. Mr. Tim Luscombe was appointed as Chief Financial Officer and Company Secretary, while Mr. Neville Gardiner retired from the Board. The changes support the company's shift towards improving execution in its commercial activities and will be detailed further in an upcoming market update.
Key Points
  • Organisational restructure to focus on commercial diagnostics.
  • 25% positions made redundant for cost efficiency.
  • Appointment of Mr Tim Luscombe as CFO and Company Secretary.
  • Retirement of Mr Neville Gardiner from the Board.
  • Strategic review details to be announced with Appendix 4C.
  • Company transitioning from research to commercial focus.
  • Annual cost savings expected to exceed $1 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.